Michela Guglieri Selected Research

Michela Guglieri Research Topics

Disease

35	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 08/2022 - 10/2009
7	Muscular Dystrophies (Muscular Dystrophy) 01/2022 - 11/2005
6	Disease Progression 08/2022 - 01/2013
3	Sarcoglycanopathies 01/2022 - 02/2008
3	Muscle Weakness 12/2021 - 01/2013
3	Cardiomyopathies (Cardiomyopathy) 10/2021 - 01/2017
2	Insulin Resistance 01/2019 - 10/2018
2	Muscular Diseases (Myopathy) 01/2018 - 03/2017
2	Glycogen Storage Disease Type II (Pompe's Disease) 07/2016 - 01/2016
2	type 2B Limb-girdle muscular dystrophy 09/2015 - 02/2008
1	Vomiting 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Osteoporosis 01/2021
1	Inflammation (Inflammations) 01/2021
1	Hirsutism 01/2020
1	Weight Gain 01/2020
1	Growth Disorders 01/2020
1	Left Ventricular Dysfunction 12/2018
1	Bone Resorption 10/2018
1	Deglutition Disorders (Dysphagia) 01/2018
1	Neuromuscular Diseases (Neuromuscular Disease) 03/2017
1	Sarcopenia 03/2017
1	Cachexia 03/2017
1	Injection Site Reaction 10/2014
1	Proteinuria 10/2014
1	Rare Diseases (Rare Disease) 08/2014
1	Bethlem myopathy 04/2014
1	Myasthenia Gravis 04/2014
1	Scleroatonic muscular dystrophy 01/2013
1	Congenital Structural Myopathies (Centronuclear Myopathy) 07/2010
1	Ophthalmoplegia (External Ophthalmoplegia) 07/2010
1	type 2C Limb-girdle muscular dystrophy 02/2008
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 02/2008
1	type 2E Limb-girdle muscular dystrophy 02/2008
1	Type 1C Limb-Girdle Muscular Dystrophy 02/2008
1	Limb-girdle muscular dystrophy type 2A 02/2008
1	Limb-girdle muscular dystrophy type 2F 02/2008
1	Type 2I Limb-Girdle Muscular Dystrophy 02/2008
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2004
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2004

Drug/Important Bio-Agent (IBA)

16	DystrophinIBA 08/2022 - 10/2009
10	Proteins (Proteins, Gene)FDA Link 08/2022 - 11/2005
7	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2013
6	GlucocorticoidsIBA 12/2021 - 01/2016
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 12/2015
4	VBP15 compoundIBA 01/2022 - 10/2018
4	Pharmaceutical PreparationsIBA 10/2021 - 08/2011
3	domagrozumabIBA 08/2022 - 01/2020
3	golodirsenIBA 01/2022 - 01/2020
3	SteroidsIBA 01/2022 - 05/2018
3	eteplirsenIBA 10/2012 - 10/2009
2	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2020
2	deflazacortIBA 01/2022 - 01/2020
2	Sarcoglycans (beta Sarcoglycan)IBA 01/2022 - 02/2008
2	atalurenIBA 12/2021 - 10/2019
2	Antisense OligonucleotidesIBA 01/2021 - 01/2014
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2017 - 09/2015
2	MorpholinosIBA 08/2011 - 10/2009
1	Nonsense Codon (Nonsense Mutation)IBA 10/2019
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	MyostatinIBA 03/2017
1	GlucosidasesIBA 07/2016
1	AcidsIBA 07/2016
1	Diphosphonates (Bisphosphonates)IBA 01/2016
1	human GAA protein (Myozyme)FDA Link 01/2016
1	GlycogenIBA 01/2016
1	Testosterone (Sustanon)FDA Link 12/2015
1	Fatty Acid Binding Protein 3IBA 09/2015
1	Myosin Light Chains (Myosin Essential Light Chain)IBA 09/2015
1	Troponin IIBA 09/2015
1	PRO051IBA 10/2014
1	Fibronectins (Fibronectin)IBA 04/2014
1	CollagenIBA 01/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Dystroglycans (Dystroglycan)IBA 12/2011
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 12/2011
1	Protein Isoforms (Isoforms)IBA 11/2011
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 07/2010
1	DysferlinIBA 02/2008

Therapy/Procedure

9	Therapeutics 12/2021 - 11/2004